晚期早产儿低血糖与儿童神经发育结局无关
本研究为产前晚期早产儿类固醇多中心随机试验的前瞻性随访,纳入6岁及以上儿童,评估出生24小时内血糖低于40 mg/dL与神经发育的关系。结果显示低血糖组与非低血糖组的GCA评分低于85的比例无差异(15.9% vs 18.5%,调整RR 1.03,95%CI 0.74-1.45),次要结局及低血糖严重程度亦无关联。
要点
- 晚期早产儿出生24小时内低血糖未增加6岁时神经发育不良风险
- 低血糖严重程度与任何神经发育结局均无关联
- 低血糖组GCA评分低于85的比例为15.9%,非低血糖组为18.5%
核心结论
- 在主要以晚期早产儿为主的队列中,新生儿低血糖与儿童神经发育结局无关。
研究设计与样本
- 前瞻性随访研究,纳入产前晚期早产儿类固醇多中心随机试验中母亲所生的6岁及以上儿童,随访于2017至2022年在13个中心进行。
- 共入组1026名儿童,1020名(99.4%)有血糖数据,944名有主要结局数据。
- 主要暴露为出生24小时内血糖低于40 mg/dL,主要结局为DAS-II的GCA评分低于85(-1 SD)的比例。
主要发现
- 944名儿童中785名(83.2%)为晚期早产,208名(22.0%)有低血糖,其中84名(40.4%)接受治疗。
- 主要结局GCA评分低于85的比例在低血糖组为15.9%,非低血糖组为18.5%,调整相对风险1.03(95%CI 0.74-1.45)。
- 次要结局(GMFCS分级、SRS-2评分、CBCL评分)及低血糖严重程度均与结局无关联。
关键数值与推荐
- 低血糖定义为出生24小时内血糖浓度低于40 mg/dL。
- 主要结局为DAS-II的GCA评分低于85(-1 SD)。
- 调整相对风险1.03(95%CI 0.74-1.45),无统计学差异。
临床怎么用
- 对于晚期早产儿,出生24小时内血糖低于40 mg/dL未显示与6岁时神经发育不良相关,可据此咨询家长。
- 低血糖严重程度亦未显示与神经发育结局相关,但需结合临床个体化评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether hypoglycemia in neonates born to mothers at risk for late preterm delivery was related to adverse effects on childhood neurodevelopment. METHODS: This was a prospective follow-up study of children aged 6 years or older whose mothers were enrolled in the Antenatal Late Preterm Steroids multicenter randomized trial. The study was conducted at 13 centers that participated in the Maternal-Fetal Medicine Units Network cycle from 2011 to 2016. Follow-up was from 2017 to 2022. Adult consent and child assent were obtained. The primary exposure was hypoglycemia , defined as a blood glucose concentration less than 40 mg/dL within 24 hours of birth. The primary outcome, proportion of GCA (General Conceptual Ability) scores lower than 85 (-1 SD) from the DAS-II (Differential Ability Scales, 2nd Edition), was analyzed by the presence of hypoglycemia at birth, irrespective of initial trial treatment assignment (betamethasone or placebo). Secondary outcomes included GMFCS (Gross Motor Function Classification System) level, SRS-2 (Social Responsiveness Scale, 2 nd Edition) scores, and CBCL (Child Behavior Checklist) scores. Univariable and multivariable analyses were performed, the latter adjusted for prespecified variables known to be associated with the primary outcome. RESULTS: Of 1,026 children enrolled, 1,020 (99.4%) had blood glucose data and 944 had data for the primary outcome. Of these 944, 785 (83.2%) were delivered late preterm and 208 (22.0%) had hypoglycemia, of whom 84 (40.4%) were treated. Those with hypoglycemia were more likely to have private insurance, have older mothers, receive betamethasone, and identify as White. There were no differences in the primary outcome, GCA score lower than 85 (15.9% in those with hypoglycemia vs 18.5% in those without; adjusted relative risk 1.03; 95% CI, 0.74-1.45), and no difference in secondary outcomes. Severity of hypoglycemia also was not associated with any outcomes. CONCLUSION: In our cohort, hypoglycemia was not associated with neurodevelopmental outcomes in children born predominantly late preterm.
引用
- Gyamfi-Bannerman C, de Voest JA, Tita ATN, et al. Child Neurodevelopmental Outcomes After Late Preterm Hypoglycemia. Obstet Gynecol. 2026. PMID: 42462244. doi:10.1097/AOG.0000000000006366
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。